SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-13-178006
Filing Date
2013-04-26
Accepted
2013-04-26 16:57:54
Documents
9
Period of Report
2013-05-29
Effectiveness Date
2013-04-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A d517934ddef14a.htm DEF 14A 1038327
2 GRAPHIC g517934g01o07.jpg GRAPHIC 13596
3 GRAPHIC g517934g13h34.jpg GRAPHIC 10542
4 GRAPHIC g517934g15n03.jpg GRAPHIC 13605
5 GRAPHIC g517934g19l78.jpg GRAPHIC 20594
6 GRAPHIC g517934g38y07.jpg GRAPHIC 14975
7 GRAPHIC g517934g48m61.jpg GRAPHIC 13616
8 GRAPHIC g517934g66y82.jpg GRAPHIC 14572
9 GRAPHIC g517934g79e77.jpg GRAPHIC 8974
  Complete submission text file 0001193125-13-178006.txt   1192778
Mailing Address 75 SIDNEY STREET 4TH FLOOR CAMBRIDGE MA 02139
Business Address 75 SIDNEY STREET 4TH FLOOR CAMBRIDGE MA 02139 6172995000
AVEO PHARMACEUTICALS INC (Filer) CIK: 0001325879 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34655 | Film No.: 13788090
SIC: 2834 Pharmaceutical Preparations